首页VBIVQ • OTCMKTS
add
VBI Vaccines Inc
昨日收盘价
$0.00050
当日价格范围
$0.00050 - $0.00060
年度波幅
$0.00020 - $0.051
市值
7170.50 USD
平均交易量
5.62万
市盈率
-
股息率
-
主要交易所
OTCMKTS
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年3月info | 年同比变化 |
|---|---|---|
收入 | 121.40万 | 150.31% |
经营支出 | 1024.20万 | -37.68% |
净收入 | -1790.00万 | 35.50% |
净利润率 | -1474.46 | 74.23% |
每股收益 | — | — |
息税折旧摊销前利润 | -1125.90万 | 40.75% |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (USD) | 2024年3月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1259.50万 | -68.82% |
总资产 | 7544.30万 | -41.27% |
负债总额 | 8091.00万 | -3.03% |
权益总额 | -546.70万 | — |
发行在外的股份 | 2868.23万 | — |
市净率 | -0.00 | — |
资产回报率 | -36.18% | — |
资本回报率 | -55.53% | — |
现金流
现金净变动
| (USD) | 2024年3月info | 年同比变化 |
|---|---|---|
净收入 | -1790.00万 | 35.50% |
来自运营的现金 | -1177.00万 | 45.65% |
投资现金 | -15.10万 | 71.72% |
融资现金 | 84.30万 | — |
现金净变动 | -1109.00万 | 50.13% |
自由现金流 | -439.98万 | 70.09% |
简介
Variation Biotechnologies Inc., also known as VBI Vaccines Inc., is a biopharmaceutical company, headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Ontario, Canada, and a research and manufacturing site in Rehovot, Israel. Its Ottawa facility has approximately thirty researchers working with National Research Council of Canada to produce a COVID-19 vaccine—VBI-2902. In August VBI received CA$56 million from the Government of Canada to prepare its vaccine for clinical trials by the end of 2020. The company's CEO, Jeff Baxter, said that VBI-2902 is cheaper to produce than other vaccines. Wikipedia
成立时间
1965
员工数量
135
